Once-weekly albiglutide in the management of type 2 diabetes: patient considerations.

Patient Prefer Adherence · 2014 · PMC4049886 · PMID 24926194

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Healthy subjects who received increasing doses of albiglutide showed a trend of dose-dependent reduction in glucose and fructosamine levels.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.